We limit data available in the Overview Report for users who do not have Powerpack
Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.
Target Price Range
Recommendation Rating
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 52.07 | 60.20 | 75.08 | 96.95 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 72.70 | 84.64 | 115.50 | 115.84 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12,882 | 12,785 | 12,694 | 12,716 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.49 | 1.46 | 1.49 | 1.35 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19,140.00 | 18,701.00 | 18,927.00 | 17,164.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 47.73% | 50.47% | 55.37% | 51.74% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,869.00 | 5,262.00 | 6,417.00 | 4,533.00 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 25.44% | 28.14% | 33.90% | 26.41% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,418.00 | 4,659.00 | 5,443.00 | 3,646.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 792.00 | 816.00 | 851.00 | 874.00 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 30.15 | 31.37 | 33.65 | 32.21 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 6.62 | 7.81 | 9.68 | 6.84 | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.11 | 5.35 | 4.81 | 4.79 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00 | 0.00 | 0.00 | 0.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.11 | 5.35 | 4.81 | 4.79 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 31.73 | 36.88 | 46.40 | 55.34 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 634.82 | 596.17 | 562.49 | 532.89 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.85 | 10.72 | 10.72 | 15.96 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.37 | 2.65 | 3.07 | 3.42 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.26 | 2.26 | 2.23 | 1.99 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.56 | 2.82 | 3.14 | 3.55 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.62 | 16.52 | 21.96 | 23.85 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,879.00 | 3,190.00 | 2,707.00 | 2,555.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| — | — | — | — | — | — | — | — | — | — | — | — | — | Capex |
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,879.00 | 3,190.00 | 2,707.00 | 2,555.00 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (92,320.00) | (86,445.00) | (70,500.00) | (62,503.00) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7,442.00 | 7,364.00 | 7,498.00 | 8,409.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,499.00 | 3,058.00 | 1,269.00 | 2,164.00 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 20,140.00 | 21,985.00 | 26,098.00 | 29,490.00 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.05% | 3.61% | 4.46% | 3.12% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 12.87% | 13.13% | 14.65% | 8.95% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 16.55% | 22.12% | 22.64% | 13.12% | — | — | — |
ROE
|
Analyst Commentary (Summary)
Aflac Incorporated (AFL) Latest News
21 Sep
Aflac posted Q2 results with higher net earnings but softer adjusted figures, and announced another dividend increase, preserving its long dividend-growth record. Near-term stock weakness persists (7-day return −1.56%, 90-day −3.04%), though 1-year and 5-year total returns are 9.49% and 141.52% respectively, signaling long-term compounding. Valuation is mixed: a 11.9x P/E sits below the peer average (16.4x) but above the industry average (11.1x), with Simply Wall St marking the ratio as OVERVALUED. Conversely, a DCF-based fair value of about $169.38 per share versus a $115.18 price implies meaningful upside. The piece notes recent declines in revenue and net income that could erode confidence if the trend persists. Overall, conflicting signals create a blended risk-reward, suggesting cautious positioning but potential upside if fundamentals align with the cash-flow view. Conflicting valuation signals (P/E vs DCF upside) imply a moderate reassessment risk without a guaranteed fundamental shift.
15 Aug
Aflac's Q2 earnings call included five analyst questions that focused on financial performance, claims trends, investment strategy, capital deployment and growth outlook in Japan and the U.S. Earnings call questions can highlight near-term operational details and investor concerns that moderately influence short-term sentiment without altering long-term company trajectory.
13 Aug
Aflac (AFL) released its Q2 2026 earnings call transcript covering quarterly financial results, management discussion, and forward outlook. Earnings call details on financial performance and outlook typically drive major shifts in stock valuation and investor positioning.
11 Aug
Aflac Q2 results feature Japan product refresh and U.S. group momentum that offset sales decline. Japan product refresh and U.S. group momentum offset sales decline with moderate effects on operations and performance.
7 Aug
Aflac Q2 earnings call highlights key quarterly financial results and operational updates for the insurer. Quarterly earnings data can shift near-term investor views on Aflac's performance and valuation.
Aflac Inc reported strong margins in Japan along with strategic updates during its Q2 2026 earnings call. Strong Japan margins and strategic highlights point to moderate positive effects on financial performance and investor views.
Aflac missed Q2 EPS estimates. The company posted solid US sales growth. Q2 EPS miss signals short-term profitability pressure offset by sales growth.
Aflac Incorporated held its Q2 2026 earnings call covering financial results and operational updates. Quarterly earnings updates deliver moderate effects on financial outlook and investor positioning.
6 Aug
Aflac reported Q2 earnings with key metrics compared against analyst estimates. Q2 earnings metrics versus estimates can shift near-term investor sentiment on Aflac performance.
29 Jul
Aflac (AFL) could be 10% above fair value on shrinking revenue views. Shrinking revenue views indicate potential 10% overvaluation that may pressure future stock performance.
2 Jul
Aflac faces a Japan cyber breach that leaves its stock appearing overvalued. Japan cyber breach may moderately affect Aflac operations and stock trajectory.
Aflac's Omnibus Shelf and Fit Checks Campaign has modified the company's investment narrative and market positioning. Campaign initiatives are altering Aflac's investment narrative without indicating transformative strategic shifts.
26 May
Morgan Stanley raised Aflac's price target to $125 citing solid insurance trends. Analyst price target increase to $125 signals moderately positive market sentiment on Aflac's insurance performance.
21 May
Aflac raises 65.9 billion yen in the Japan bond market as part of rising activity by foreign issuers. Bond issuance supplies Aflac with fresh yen capital that supports operations and liquidity in its core Japan market.
20 May
Aflac issues yen-denominated bonds in Japan's surging market, mirroring Alphabet to secure favorable long-term funding amid local demand. Yen bond issuance offers Aflac cheaper capital and currency matching but remains a routine financing step rather than a core business shift.
17 May
Aflac Incorporated faces three key risks that position it as a questionable investment, leading to a recommendation for buying an alternative stock instead. Three highlighted risks for AFL may moderately affect near-term investor sentiment and stock performance.
13 May
Aflac (AFL) valuation comes under review after softer margins in Japan and a quarterly earnings miss. Earnings miss and softer Japan margins signal moderate pressure on financial performance amid key market challenges.
2 May
Analysts are resetting price targets and earnings paths for Aflac Incorporated (AFL), driving a shift in the company's narrative. Analyst resets to price targets and earnings paths signal major changes in investor expectations and Aflac's market trajectory.
Aflac Incorporated (AFL) Q1 results missed expectations, with Japan sales growth offset by premium pressures. Q1 earnings miss from premium pressures despite Japan sales signals moderate financial impact balanced by regional strengths.
1 May
Aflac Incorporated released highlights from its Q1 earnings call, covering financial results, operational updates, and forward guidance. Q1 earnings call highlights detail financial performance and guidance, significantly influencing Aflac's stock trajectory and investor sentiment.
Aflac Incorporated's Q1 earnings missed analyst estimates, driven by lower investment income amid challenging market conditions. Q1 earnings miss from lower investment income will moderately affect Aflac's financial performance and short-term market sentiment.
30 Apr
Aflac reported surging earnings and hiked its dividend, signaling strong financial health and delivering enhanced returns for shareholders. Earnings surge and dividend increase demonstrate robust financial performance, likely boosting investor sentiment and stock trajectory.
Aflac Incorporated's Q1 2026 earnings call summary details quarterly financial results, Japan and U.S. segment performance, dividend increases, share repurchases, and optimistic outlook amid favorable interest rates and growth strategies. Quarterly earnings summaries influence financial performance and investor sentiment through reported metrics, guidance, and strategic updates.
29 Apr
Aflac (AFL) reported Q1 earnings, analyzing key metrics for performance insights. Q1 earnings reports with key metrics analysis significantly influence AFL's stock price, investor sentiment, and future trajectory.
Aflac Incorporated (NYSE: AFL) exceeded expectations for Q1 CY2026. Exceeding Q1 CY2026 expectations indicates strong financial results that could significantly boost stock performance and investor sentiment.
Aflac Incorporated announced first quarter 2026 results. Quarterly earnings releases significantly affect financial performance metrics and investor sentiment.
Aflac Incorporated's Q1 earnings and revenues missed analyst estimates. Q1 earnings and revenue misses highlight weaker-than-expected financial performance, likely causing moderate short-term pressure on stock price and investor sentiment.
28 Apr
Aflac Incorporated (AFL) reports Q1 results tomorrow. Q1 earnings reports often drive significant shifts in stock price and investor sentiment for Aflac.
Aflac's Q1 earnings release nears, with analysts providing insights on key performance measures like revenue, earnings per share, and segment growth. Pre-earnings analyst previews on key metrics can moderately influence investor sentiment and Aflac's near-term financial performance perception.
23 Apr
Aflac's Japan business could drive a strong Q1 earnings beat, leveraging its key market for growth amid expectations of solid performance. Japan operations' potential to exceed Q1 earnings expectations may noticeably boost short-term financial results and investor sentiment.
Aflac Incorporated (AFL) has showcased remarkable resilience as a supplemental insurance leader in the U.S. and Japan, quadrupling its stock price from 2016 lows near $27 to recent highs above $115 despite revenue contraction from $22.6 billion in 2016 to $18.9 billion in 2023, driven by yen depreciation impacting its Japan-heavy premiums (over 70%). As a dividend aristocrat with 40+ years of increases, aggressive buybacks halved shares outstanding to 562 million, boosting revenue per share +23% and EPS +200% to $9.68, while gross margins expanded 51% to 55.4% and ROE hit 22.6%—far above sector norms—fueled by pricing discipline, favorable claims, and Japan product shifts.
A robust balance sheet underpins this, with book value per share doubling to $46.40, net debt down 58%, and ROIC at 14.7%, enabling $2.7 billion in free cash flow to fund returns. Valuation appears reasonable at 14-15x forward PE versus historical 7-12x, though insider selling totaling $18.4 million (no buys) signals caution amid yen risks.
Projections show revenue dipping to $17.2 billion in 2024 before stabilizing, EPS normalizing to $7.35-$7.72, with margins supporting 8-12% total returns through 2028 via dividends and buybacks. While yen weakness and regulations pose risks, Aflac’s per-share leverage and efficiency trends validate its defensive appeal—monitor Q1 2026 for Japan momentum.